Published in Blood Weekly, December 25th, 2003
The research, published in Blood online, suggests that therapies designed for long-term cure of the disease should target this stem cell, which, unlike other cells, can copy itself and differentiate into one or more specialized cell types.
In their studies to learn why multiple myeloma so often recurs following drug treatment, the investigators uncovered a rare stem cell, occurring in just 1 out of every 10,000 cells or less than 1% of all myeloma...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-12-25)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.